Borosil Scientific Q2 Results FY27: PAT Rises 86.32% to Rs 5.31 Cr, Revenue Rs 114.96 Cr

Borosil Scientific Ltd Q2 Results FY27 announced on 28 October 2026, covering the company's financial performance for the July to September quarter. The results date brought consolidated revenue of Rs 114.96 Cr and net profit (PAT) of Rs 5.31 Cr. Borosil Scientific Q2 Results FY27 therefore pair a rise in sales with a much larger rise in profit, and these consolidated results frame the analysis below.

This results analysis of Borosil Scientific Q2 Results covers the financial highlights, business drivers, outlook and risks. It begins with the Financial Highlights table, assembled from the figures Univest tracks for each listed company as it reports.

Click Here – Get Free Investment Predictions

Borosil Scientific Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 114.96 Cr	Rs 106.9 Cr	+7.54% YoY
Operating Profit	Rs 10.7 Cr	Rs 8.03 Cr	+33.25% YoY
Net Profit (PAT)	Rs 5.31 Cr	Rs 2.85 Cr	+86.32% YoY

Source: company filing for Borosil Scientific Q2 Results FY27, 28 October 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Borosil Scientific Q2 Results: What Stands Out

• Revenue YoY growth of 7.54%: consolidated revenue reached Rs 114.96 Cr against Rs 106.90 Cr in the same quarter of last year.
• Net profit up 86.32%: Borosil Scientific Q2 Results FY27 show net profit of Rs 5.31 Cr compared with Rs 2.85 Cr a year earlier, a gain of Rs 2.46 Cr.
• Operating Profit Rs 10.70 Cr: this line rose 33.25% YoY from Rs 8.03 Cr, a gain of Rs 2.67 Cr that moved with net profit.
• Margin gain: net profit margin improved to 4.6% from 2.7% in the comparison quarter, so profit grew faster than sales.
• Balance sheet: the debt-to-assets ratio was 0.02 in FY26, a full-year figure that shows almost no borrowing.

Borosil Scientific Q2 Results FY27: Performance Analysis

Borosil Scientific Q2 Results FY27 show consolidated revenue of Rs 114.96 Cr, up 7.54% from Rs 106.90 Cr, while net profit rose 86.32% to Rs 5.31 Cr from Rs 2.85 Cr. Operating Profit of Rs 10.70 Cr was 33.25% higher than the Rs 8.03 Cr recorded a year earlier. Profit therefore grew far faster than sales.

Within Borosil Scientific Q2 Results FY27, the size of each change is the central point of the results analysis. Revenue added Rs 8.06 Cr YoY, Operating Profit added Rs 2.67 Cr and net profit added Rs 2.46 Cr. A wider net profit margin of 4.6%, against 2.7% a year earlier, links these moves in the consolidated statement.

Investors tracking Borosil Scientific Q2 Results will read the quarter against the range of recent profits, since quarterly net profit has ranged from Rs 2.85 Cr to Rs 27.21 Cr over the last 5 quarters. The latest figure therefore sits well below the top of that range.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points first to revenue, which grew 7.5% year on year to Rs 114.96 Cr in the latest quarter. This is the disclosed top-line factor behind the consolidated figures.

Profit Growth – Net profit rose 86.3% year on year to Rs 5.31 Cr, and the net profit margin improved to 4.6% from 2.7% in the comparison quarter. Each rupee of sales therefore left more profit than a year earlier.

Low Debt – The company is almost debt free, with a debt-to-assets ratio of 0.02 in FY26. This full-year measure describes the balance sheet that stands behind the latest quarter.

FY27 Outlook After Borosil Scientific Q2 Results

Full-year FY27 results for Borosil Scientific will turn on the quarters still to be reported, and the July to September 2026 period is one input. On a results analysis basis, Rs 5.31 Cr of net profit sets the comparison for the next filing.

Borosil Scientific Q2 Results FY27 leave two reference points for the rest of the year: revenue growth of 7.54% and net profit growth of 86.32%. Investors can follow later disclosures on the Univest Screener and the Univest app, which brings the discussion to the risks.

Key Risks to Watch After Borosil Scientific Q2 Results FY27

Low Return on Equity

Return on equity was low at 8.42% in FY26. Borosil Scientific Q2 Results FY27 show a strong quarter, so investors will watch whether later filings lift this full-year return.

Lower Annual Profit Per Share

Annual profit per share has slipped between FY23 and FY26. This is a multi-year record that the latest quarter sits against, and later filings will show whether the slide continues.

Volatile Quarterly Profit

Quarterly net profit has been volatile, ranging from Rs 2.85 Cr to Rs 27.21 Cr over the last 5 quarters. The next filing will show where profit settles within that range.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Borosil Scientific Q2 Results FY27 show consolidated revenue of Rs 114.96 Cr and net profit of Rs 5.31 Cr, which means higher sales and much higher profit in the quarterly results. The moves are on record as consolidated results in the filing dated 28 October 2026. Anyone reading Borosil Scientific Q2 Results should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Borosil Scientific Q2 Results FY27

What are Borosil Scientific Q2 Results FY27?

Ans. Borosil Scientific Q2 Results FY27 are the Consolidated July to September 2026 results of Borosil Scientific, with revenue of Rs 114.96 Cr and net profit of Rs 5.31 Cr, as the Quick Answer summarises.

What is the results date for Borosil Scientific Q2 Results FY27?

Ans. Borosil Scientific declared the quarter on 28 October 2026, so the results date covers the July to September 2026 period, while the introduction explains the consolidated basis of the figures.

What revenue was reported in Borosil Scientific Q2 Results FY27?

Ans. Borosil Scientific reported consolidated revenue of Rs 114.96 Cr, against Rs 106.90 Cr a year earlier, so revenue added Rs 8.06 Cr, as the Financial Highlights table shows.

What net profit was reported in Borosil Scientific Q2 Results FY27?

Ans. Borosil Scientific Q2 Results FY27 show net profit of Rs 5.31 Cr against Rs 2.85 Cr in the same quarter last year, so profit rose by Rs 2.46 Cr, as the Key Takeaways section notes.

How much YoY growth did net profit show in Borosil Scientific Q2 Results FY27?

Ans. Net profit grew 86.32% YoY in the July to September quarter, from Rs 2.85 Cr to Rs 5.31 Cr, while revenue rose 7.54%, as the Performance Analysis explains.

Did revenue rise or fall in Borosil Scientific Q2 Results?

Ans. Borosil Scientific revenue rose 7.54% YoY to Rs 114.96 Cr from Rs 106.90 Cr, and net profit rose faster than revenue, as the Performance Analysis section discusses.

What was the Operating Profit in Borosil Scientific Q2 Results FY27?

Ans. Operating Profit was Rs 10.70 Cr, up 33.25% from Rs 8.03 Cr a year earlier, so it grew faster than the 7.54% YoY revenue growth, as the Key Takeaways section outlines.

Are Borosil Scientific Q2 Results consolidated results or standalone results?

Ans. The figures are Consolidated results, covering Borosil Scientific together with its group entities, so every revenue and profit number in the article follows the consolidated basis stated in the introduction.

What business factors shaped Borosil Scientific Q2 Results FY27?

Ans. The disclosed factors are revenue growth of 7.5% YoY, an 86.3% rise in net profit, a net profit margin of 4.6% against 2.7%, and a debt-to-assets ratio of 0.02 in FY26.

What are the key risks after Borosil Scientific Q2 Results FY27?

Ans. The listed risks are a low return on equity of 8.42% in FY26, a slide in annual profit per share since FY23, and quarterly net profit that ranged from Rs 2.85 Cr to Rs 27.21 Cr.

What is the outlook after Borosil Scientific Q2 Results?

Ans. FY27 full-year results will depend on the quarters still to be reported, while Rs 5.31 Cr of quarterly net profit and 7.54% revenue growth are the reference points, as the Outlook section states.

Where can I find the complete Borosil Scientific Q2 Results FY27 data?

Ans. The Financial Highlights table in this article carries the full revenue and net profit comparison, while the Univest Screener lets investors follow Borosil Scientific filings alongside other listed companies.